Demaulo, Laufred C.
HRN: 21-46-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFTRIAXONE 1G (VIAL)
06/16/2022
06/23/2022
IV
1gm
Q12
Fracture, Open Reduction
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes